SK284974B6 - Medziprodukty na výrobu a spôsob výroby proteázového inhibítora - Google Patents

Medziprodukty na výrobu a spôsob výroby proteázového inhibítora Download PDF

Info

Publication number
SK284974B6
SK284974B6 SK226-2000A SK2262000A SK284974B6 SK 284974 B6 SK284974 B6 SK 284974B6 SK 2262000 A SK2262000 A SK 2262000A SK 284974 B6 SK284974 B6 SK 284974B6
Authority
SK
Slovakia
Prior art keywords
acid
formula
cvi
hydroxylactone
group
Prior art date
Application number
SK226-2000A
Other languages
English (en)
Slovak (sk)
Other versions
SK2262000A3 (en
Inventor
James R. Gage
Robert C. Kelly
Bradley D. Hewitt
Original Assignee
Pharmacia & Upjohn Company
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmacia & Upjohn Company filed Critical Pharmacia & Upjohn Company
Publication of SK2262000A3 publication Critical patent/SK2262000A3/sk
Publication of SK284974B6 publication Critical patent/SK284974B6/sk

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C205/00—Compounds containing nitro groups bound to a carbon skeleton
    • C07C205/49—Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by carboxyl groups
    • C07C205/56—Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by carboxyl groups having nitro groups bound to carbon atoms of six-membered aromatic rings and carboxyl groups bound to acyclic carbon atoms of the carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/27—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by oxidation
    • C07C45/30—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by oxidation with halogen containing compounds, e.g. hypohalogenation
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C47/00—Compounds having —CHO groups
    • C07C47/20—Unsaturated compounds having —CHO groups bound to acyclic carbon atoms
    • C07C47/277—Unsaturated compounds having —CHO groups bound to acyclic carbon atoms containing ether groups, groups, groups, or groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C59/40—Unsaturated compounds
    • C07C59/42—Unsaturated compounds containing hydroxy or O-metal groups
    • C07C59/48—Unsaturated compounds containing hydroxy or O-metal groups containing six-membered aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/32—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Virology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • AIDS & HIV (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pyrane Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Pyridine Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
SK226-2000A 1997-09-11 1998-09-03 Medziprodukty na výrobu a spôsob výroby proteázového inhibítora SK284974B6 (sk)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US5861897P 1997-09-11 1997-09-11
PCT/US1998/017993 WO1999012919A1 (en) 1997-09-11 1998-09-03 Process to produce 4-hydroxy-2-oxo-pyrane derivates useful as protease inhibitors

Publications (2)

Publication Number Publication Date
SK2262000A3 SK2262000A3 (en) 2000-10-09
SK284974B6 true SK284974B6 (sk) 2006-03-02

Family

ID=22017924

Family Applications (1)

Application Number Title Priority Date Filing Date
SK226-2000A SK284974B6 (sk) 1997-09-11 1998-09-03 Medziprodukty na výrobu a spôsob výroby proteázového inhibítora

Country Status (20)

Country Link
US (2) US6077963A (cs)
EP (1) EP1015441B1 (cs)
JP (3) JP4462760B2 (cs)
KR (1) KR100569771B1 (cs)
CN (3) CN100471832C (cs)
AT (1) ATE266654T1 (cs)
CA (1) CA2300204C (cs)
CZ (1) CZ298847B6 (cs)
DE (1) DE69823844T2 (cs)
DK (1) DK1015441T3 (cs)
ES (1) ES2221199T3 (cs)
FI (1) FI120973B (cs)
HU (1) HU228986B1 (cs)
NO (1) NO321835B1 (cs)
NZ (1) NZ503338A (cs)
PL (1) PL193240B1 (cs)
PT (1) PT1015441E (cs)
RU (2) RU2223958C2 (cs)
SK (1) SK284974B6 (cs)
WO (1) WO1999012919A1 (cs)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1161427B1 (en) * 1999-03-18 2002-10-23 PHARMACIA & UPJOHN COMPANY Improved process for asymmetric hydrogenation
US6552204B1 (en) * 2000-02-04 2003-04-22 Roche Colorado Corporation Synthesis of 3,6-dialkyl-5,6-dihydro-4-hydroxy-pyran-2-one
US6500963B2 (en) 2001-02-22 2002-12-31 Boehringer Ingelheim Pharma Kg Process for preparing optically active dihydropyrones
DE10108470A1 (de) * 2001-02-22 2002-09-05 Boehringer Ingelheim Pharma Verfahren zur Herstellung optisch aktiver Dihydropyrone
US6987123B2 (en) 2001-07-26 2006-01-17 Cadila Healthcare Limited Heterocyclic compounds, their preparation, pharmaceutical compositions containing them and their use in medicine
BR0215593A (pt) 2002-02-07 2004-12-21 Sumitomo Chemical Co Processo para produzir ácido (r)-3-hidróxi-3-(2-feniletil)-hexanóico e seu intermediário
DE10313118A1 (de) * 2003-03-24 2004-10-07 Boehringer Ingelheim Pharma Gmbh & Co. Kg Enantioselektive Hydrierung von Intermediaten bei der Tipranavir-Synthese
US7512945B2 (en) * 2003-12-29 2009-03-31 Intel Corporation Method and apparatus for scheduling the processing of commands for execution by cryptographic algorithm cores in a programmable network processor
CN100448836C (zh) * 2005-06-03 2009-01-07 浙江中贝化工有限公司 一种抗艾滋病药物关键中间体的制备方法
EP1928878A1 (en) * 2005-08-24 2008-06-11 Pfizer Inc. Methods for the preparation of hcv polymerase inhibitors
CN101878553A (zh) * 2007-11-30 2010-11-03 株式会社半导体能源研究所 发光元件、发光装置以及电子装置
US8853393B2 (en) * 2011-07-29 2014-10-07 Anhui New Star Pharmaceutical Development Co., Ltd. Intermediate for preparing tapentadol or analogues thereof

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1355668A (fr) * 1963-02-05 1964-03-20 Moteur rotatif à combustion interne perfectionné
FR1355667A (fr) * 1963-02-05 1964-03-20 Meci Materiel Elect Contr Gaine tubulaire pour électrode servant à la mesure du ph
FR2096877B1 (cs) * 1970-07-09 1973-08-10 Hexachimie
JPH0665657B2 (ja) * 1984-11-08 1994-08-24 日本化薬株式会社 光学活性マンデル酸の製法
JPH072677B2 (ja) * 1988-02-19 1995-01-18 株式会社クラレ （±）―２―ヒドロキシ―４―フェニルブタン酸の光学分割法
JPH01221345A (ja) * 1988-02-27 1989-09-04 Ajinomoto Co Inc マンデル酸誘導体の光学分割方法
JP3084577B2 (ja) * 1991-09-27 2000-09-04 山川薬品工業株式会社 光学活性なアトロラクチン酸の製造方法および製造の中間体
JP3178086B2 (ja) * 1992-06-17 2001-06-18 山川薬品工業株式会社 光学活性α−メチルベンジルアミンの製造方法
ZA938019B (en) * 1992-11-13 1995-04-28 Upjohn Co Pyran-2-ones and 5,6-dihydropyran-2-ones useful for treating HIV and other retroviruses
JP3684426B2 (ja) * 1993-11-19 2005-08-17 パーク・デイビス・アンド・カンパニー プロテアーゼ阻害剤および抗ウイルス剤としての５，６−ジヒドロピロン誘導体
IL129871A (en) * 1994-05-06 2003-11-23 Pharmacia & Upjohn Inc Process for preparing 4-phenyl-substituted octanoyl-oxazolidin-2-one intermediates that are useful for preparing pyran-2-ones useful for treating retroviral infections
RU2074169C1 (ru) * 1995-05-10 1997-02-27 Акционерное общество открытого типа "Химпром" Способ получения этилового эфира п-нитробензойной кислоты

Also Published As

Publication number Publication date
JP5016621B2 (ja) 2012-09-05
PL339138A1 (en) 2000-12-04
CZ2000804A3 (cs) 2000-08-16
HK1030418A1 (en) 2001-05-04
EP1015441B1 (en) 2004-05-12
KR100569771B1 (ko) 2006-04-11
RU2263106C2 (ru) 2005-10-27
CN1298714C (zh) 2007-02-07
CN1990452A (zh) 2007-07-04
DK1015441T3 (da) 2004-07-26
CA2300204C (en) 2006-12-12
PL193240B1 (pl) 2007-01-31
HK1063776A1 (en) 2005-01-14
HK1104027A1 (zh) 2008-01-04
HUP0003593A3 (en) 2002-12-28
DE69823844D1 (de) 2004-06-17
CN100471832C (zh) 2009-03-25
RU2223958C2 (ru) 2004-02-20
DE69823844T2 (de) 2005-04-14
JP5266194B2 (ja) 2013-08-21
JP2001515895A (ja) 2001-09-25
FI120973B (fi) 2010-05-31
NO321835B1 (no) 2006-07-10
US6265604B1 (en) 2001-07-24
HUP0003593A2 (hu) 2001-02-28
CN1284763C (zh) 2006-11-15
CN1511820A (zh) 2004-07-14
JP2010090157A (ja) 2010-04-22
AU743496B2 (en) 2002-01-24
CZ298847B6 (cs) 2008-02-27
NO20001274L (no) 2000-05-10
WO1999012919A1 (en) 1999-03-18
JP4462760B2 (ja) 2010-05-12
SK2262000A3 (en) 2000-10-09
NO20001274D0 (no) 2000-03-10
KR20010023864A (ko) 2001-03-26
US6077963A (en) 2000-06-20
FI20000553L (fi) 2000-03-10
PT1015441E (pt) 2004-08-31
NZ503338A (en) 2002-03-01
ATE266654T1 (de) 2004-05-15
AU9296598A (en) 1999-03-29
JP2009138002A (ja) 2009-06-25
EP1015441A1 (en) 2000-07-05
HU228986B1 (en) 2013-07-29
CN1268947A (zh) 2000-10-04
RU2003131081A (ru) 2005-04-10
ES2221199T3 (es) 2004-12-16
CA2300204A1 (en) 1999-03-18

Similar Documents

Publication Publication Date Title
JP5266194B2 (ja) プロテアーゼインヒビターとして有用な４−ヒドロキシ−２−オキソ−ピラン誘導体の製法
FR2473519A1 (fr) Terpenoides contenant deux groupes fonctionnels, leur preparation et leur application therapeutique
AU743496C (en) Process to produce 4-hydroxy-2-oxo-pyrane derivates useful as protease inhibitors
WO2002022618A1 (fr) Preparation de la camptothecine et de ses derives
FR2615735A1 (fr) Compositions therapeutiques a base de nouveaux (o-ammonio acyloxy methylene)-5 tetrahydrofuranes et tetrahydrothiophenes
MXPA00002411A (en) Process to produce 4-hydroxy-2-oxo-pyrane derivates useful as protease inhibitors
FR2615855A1 (fr) Nouveaux methoxy-5 alcoyl ammonium tetrahydrofuranes et tetrahydrothiophenes ainsi que leur procede de preparation
FR2595350A1 (fr) Procede de couplage biarylique, catalyseur au ruthenium pour sa mise en oeuvre et nouveaux composes en resultant
EP0818447B1 (de) 6-(Hydroxymethyl-ethyl)pyridine als HMG-CoA-Reduktase Inhibitoren
HK1104027B (en) Compounds useful to produce a protease inhibitor
HK1030418B (en) Process to produce 4-hydroxy-2-oxo-pyrane derivates useful as protease inhibitors
JPS62111966A (ja) （±）−パニクリジンｂの製造方法
FR2794123A1 (fr) Preparation de derives de la camptothecine et de la nothapodytine
HK1063776B (en) Compounds usefull to produce a protease inhibitors
EP0282897A2 (de) Aethinyl- und Aethenyl-Styryl-ketone

Legal Events

Date Code Title Description
MK4A Expiry of patent

Expiry date: 20180903